The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies.
about
Abdominal metastases from colorectal cancer: intraperitoneal therapyMalignant peritoneal mesothelioma.Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: national cancer institute, Mexico city, Mexico.Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers.Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patientsSiRNA-mediated reduction of alpha-actinin-1 inhibits pressure-induced murine tumor cell wound implantation and enhances tumor-free survivalA systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma.Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C.Current status and future directions: management of colon cancer with peritoneal dissemination.Impact of preoperative therapy on patterns of recurrence in pancreatic cancerA comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC.Management of peritoneal carcinomatosis from colorectal cancer.Peritoneal debulking/intraperitoneal chemotherapy-non-sarcoma.Colchicine inhibits pressure-induced tumor cell implantation within surgical wounds and enhances tumor-free survival in mice.Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy.Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options.Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy.HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.Conflicting Data on the Incidence of Leukopenia and Neutropenia After Heated Intraperitoneal Chemotherapy with Mitomycin C.Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome.A novel nomogram for peritoneal mesothelioma predicts survival.Surgery for peritoneal mesothelioma.Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients.Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
P2860
Q26772268-3452433B-A030-42BB-B9BA-D5818FEB2557Q34390899-21CCC3E8-8902-49F0-B4B1-54727B0DF29AQ35412031-D628286B-F7AB-4FE1-8FA2-3A1D8233F5CBQ35915699-8B7AC068-4C8E-4585-8E25-EA1D8D37D6C1Q36063487-6B3C5EFE-2553-4425-A64F-A5C801A3804FQ36485279-E7EF8508-5F13-425E-8DD6-388DA2E1379AQ36665886-33E235FD-21CF-4AA7-A7DD-4F2BE4295BC4Q37166451-6AD161E4-938F-448B-BCBA-514D89C4CA52Q37264971-A031BA9F-9F81-49AA-B7AA-6A250EFF316BQ37298660-FCFADC06-8514-47CA-AB28-1CA2C9149C27Q37480832-82E229EA-8473-418F-90A0-D36F475B25D1Q37597149-D49A3E68-DBEE-4F8D-914F-E4A290EB2C81Q37655525-C6388594-328E-470E-8753-33A1E383925EQ37910396-6B88314F-D57B-4087-BC74-AD9A9C12E0C6Q38156108-8476CAA5-0D75-4497-B199-B97AE7EFCCB1Q39950468-189F7CA4-8E4F-4FAD-8A7E-5845A3B7EB5CQ41649404-5F695126-95BD-485A-8C28-7CDE3646D25FQ42398293-7606DD59-09FE-4034-ABE1-40653EE6837EQ43505767-8A2FBBA8-B77F-4D4B-B21F-239C14568D5DQ46656530-6DDFEFDA-C748-4DDA-873B-E9651F3E244DQ47805880-58AD60D6-EE6F-4608-A52F-28D197BADFD5Q51120959-BFDC0A43-D7B3-417A-A58C-3E28BB7011DCQ51288705-4AE176E3-F9A4-408F-A333-462D962EF37EQ51485434-05D5AC91-17ED-4A16-A3CF-C1FAB0308CA0Q55058359-5DE720EB-2461-4917-AA50-A486E47D85C9Q58773636-741E719D-CDDC-48B7-8128-C7A9759CFF06
P2860
The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The rationale of perioperative ...... ritoneal surface malignancies.
@ast
The rationale of perioperative ...... ritoneal surface malignancies.
@en
type
label
The rationale of perioperative ...... ritoneal surface malignancies.
@ast
The rationale of perioperative ...... ritoneal surface malignancies.
@en
prefLabel
The rationale of perioperative ...... ritoneal surface malignancies.
@ast
The rationale of perioperative ...... ritoneal surface malignancies.
@en
P1476
The rationale of perioperative ...... ritoneal surface malignancies.
@en
P2093
Matthew H Katz
Robert M Barone
P304
P356
10.1016/S1055-3207(03)00034-6
P577
2003-07-01T00:00:00Z